Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Pres., R&D, and CMO

SVP and General Counsel

President and CEO

Chief Commercial Officer

Chief Financial Officer

Senior VP, Chief Pharma Dev.

Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of non-alcoholic steatohepatitis (NASH) in the United States. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor beta agonist, which is in Phase III clinical trials for treating NASH. The company is also developing MGL-3745, a backup compound to resmetirom. The company is headquartered in West Conshohocken, Pennsylvania.

Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment o...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-04-08	Premium	acquired	Premium	Premium	Premium	Pres., R&D, and CMO
2024-04-08	Premium	sold	Premium	Premium	Premium	-
2024-04-08	Premium	acquired	Premium	Premium	Premium	-
2024-04-08	Premium	sold	Premium	Premium	Premium	Pres., R&D, and CMO
2024-04-05	Premium	acquired	Premium	Premium	Premium	Pres., R&D, and CMO
2024-04-05	Premium	acquired	Premium	Premium	Premium	-
2024-04-05	Premium	sold	Premium	Premium	Premium	-
2024-04-05	Premium	sold	Premium	Premium	Premium	Pres., R&D, and CMO
2024-04-04	Premium	acquired	Premium	Premium	Premium	Pres., R&D, and CMO
2024-04-04	Premium	sold	Premium	Premium	Premium	Pres., R&D, and CMO
2024-04-04	Premium	acquired	Premium	Premium	Premium	-
2024-04-04	Premium	sold	Premium	Premium	Premium	-
2024-04-03	Premium	sold	Premium	Premium	Premium	Pres., R&D, and CMO
2024-04-03	Premium	acquired	Premium	Premium	Premium	-
2024-04-03	Premium	sold	Premium	Premium	Premium	-
2024-04-03	Premium	acquired	Premium	Premium	Premium	Pres., R&D, and CMO
2024-04-02	Premium	sold	Premium	Premium	Premium	-
2024-04-02	Premium	acquired	Premium	Premium	Premium	-
2024-04-02	Premium	sold	Premium	Premium	Premium	-
2024-04-02	Premium	acquired	Premium	Premium	Premium	-
2024-04-01	Premium	acquired	Premium	Premium	Premium	-
2024-04-01	Premium	sold	Premium	Premium	Premium	-
2024-04-01	Premium	acquired	Premium	Premium	Premium	-
2024-04-01	Premium	sold	Premium	Premium	Premium	-
2024-04-01	Premium	acquired	Premium	Premium	Premium	-

MDGL - Madrigal Pharmaceuticals Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for MDGL